Guideline-Directed Medical Therapy in PAD: Time to Step on the Gas
- PMID: 36792258
- DOI: 10.1016/j.jcin.2022.10.015
Guideline-Directed Medical Therapy in PAD: Time to Step on the Gas
Keywords: medical therapy; outcomes; peripheral artery disease; revascularization.
Conflict of interest statement
Funding Support and Author Disclosures Dr Hess has received salary support from CPC, a nonprofit academic research organization affiliated with the University of Colorado, that receives research grant/consulting funding from Abbott, Agios, Alexion Pharma, Amgen, AstraZeneca, Bayer, Better Therapeutics, Brigham and Women’s Hospital, Bristol Myers Squibb, Cambrian Biopharma, Cook Medical, Cook Regentec, Eidos Therapeutics, EPG Communications Holdings, Epizon Pharma, Exicon Consulting, Faraday, Insmed, Janssen, Lexicon, Medpace, Merck, Novo Nordisk, PPD Development, Prothena Biosciences, Regeneron, Regio Biosciences, Sanifit Therapeutics, Regents of the University of Colorado, Stealth BioTherapeutics, VarmX, and Wraser. Dr Bonaca has received support from CPC and the American Heart Association Strategically Focused Research Network (SFRN) under award numbers 18SFRN3390085 (BWH-DH SFRN Center) and 18SFRN33960262 (BWH-DH Clinical Project); and holds stock in Medtronic and Pfizer.
Comment on
-
Guideline-Directed Medical Therapy and Long-Term Mortality and Amputation Outcomes in Patients Undergoing Peripheral Vascular Interventions.JACC Cardiovasc Interv. 2023 Feb 13;16(3):332-343. doi: 10.1016/j.jcin.2022.09.022. JACC Cardiovasc Interv. 2023. PMID: 36792257 Free PMC article.
Similar articles
-
Clinical considerations after endovascular therapy of peripheral artery disease.Expert Rev Cardiovasc Ther. 2021 May;19(5):369-378. doi: 10.1080/14779072.2021.1914590. Epub 2021 Apr 19. Expert Rev Cardiovasc Ther. 2021. PMID: 33870848 Review.
-
High on-treatment platelet reactivity and outcomes after percutaneous endovascular procedures in patients with peripheral artery disease.Vasa. 2016;45(2):155-61. doi: 10.1024/0301-1526/a000510. Vasa. 2016. PMID: 27058802
-
VOYAGER PAD contributes to medical therapy for peripheral artery disease.J Vasc Surg. 2020 Dec;72(6):1843-1844. doi: 10.1016/j.jvs.2020.06.101. J Vasc Surg. 2020. PMID: 33222822 No abstract available.
-
Ticagrelor in Peripheral Artery Disease Endovascular Revascularization (TI-PAD): Challenges in clinical trial execution.Vasc Med. 2018 Dec;23(6):513-522. doi: 10.1177/1358863X18760996. Epub 2018 Apr 9. Vasc Med. 2018. PMID: 29629845 Clinical Trial.
-
Peripheral Artery Disease: Evolving Role of Exercise, Medical Therapy, and Endovascular Options.J Am Coll Cardiol. 2016 Mar 22;67(11):1338-57. doi: 10.1016/j.jacc.2015.12.049. J Am Coll Cardiol. 2016. PMID: 26988957 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical